SEARCH

SEARCH BY CITATION

References

  • 1
    Goodkind D. Abortion in Viet Nam: measurement, puzzles, and concerns. Stud Fam Plann 1994;25: 342352.
  • 2
    World Health Organization Task Force on post-ovulatory methods of fertility regulation. Termination of pregnancy with reduced doses of mifepristone. BMJ 1993;307: 532537.
  • 3
    Ngoc N, Winikoff B, Clark S, et al. Safety, efficacy and acceptability of mifepristone–misoprostol medical abortion in Viet Nam. Int Fam Plann Perspect 1999;25(1):1014.
  • 4
    World Health Organization Task Force on post-ovulatory methods of fertility regulation. Comparison of two doses of mifepristone in combination with misoprostol for early abortion: a randomised trial. Br J Obstet Gynaecol 2000;107: 524530.
  • 5
    Elul B, Hajri S, Ngoc N, et al. Can women in developing countries use a simplified medical abortion regimen of 200 mg mifepristone followed by home administration of misoprostol? Lancet 2001;357: 14021405.
  • 6
    Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administration at home after mifepristone (RU486) for abortion. J Fam Pract 1997;44: 353360.
  • 7
    Guengant JP, Bangou J, Elul B, Ellertson C. Mifepristone–misoprostol medical abortion: home administration of misoprostol in Guadeloupe. Contraception 1999;60: 167172.
  • 8
    Blum J, Hajri S, Chélli H, Ben Mansour F, Gueddana N, Winikoff B. The medical abortion experiences of married and unmarried women in Tunis, Tunisia. Contraception 2004;69(1):6369.
  • 9
    Winikoff B, Ellertson C, Clark S. Analysis of failure in medical abortion. Contraception 1996;54: 323327.
  • 10
    Hedley A, Trussell J, Turner AN, et al. Differences in efficacy, differences in providers: results from a hazard analysis of medical abortion. Contraception 2004;69: 157163.